Molecular Biology Techniques Flashcards

1
Q

DNA techniques, clinical applications and emerging applications

A
  • Restriction Enzyme Digestion, Southern Blotting, conventional sequencing & PCR
  • Identification of mutations and infectious agents
  • Prenatal screening
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

mRNA techniques, clinical applications and emerging applications

A
  • Northern Blotting, RT-PCR, microarray analysis
  • Breast cancer stratification
  • occular melanoma & breast cancer subtypes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Protein techniques, clinical applications and emerging applications

A
  • ELISA & Western blotting
  • Diagnosis of infectious diseases
  • Therapeutic antibodies
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Emerging molecular techniques:

A

“Next generation” sequencing & RNA Interference

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Restriction enzyme digestion:

A

*Used to ID DNA
*Used to recombine DNAs
Restriction enzyme binds and makes a DOUBLE-stranded cut creating a characteristic set of fragments, which can be used to identify pieces of DNA. (“restriction enzyme digestion”.)
100’s of enzymes recognizing different sites are known making restriction enzymes extremely useful for molecular biology.
EcoR1 recognizes and binds to the double stranded (ds) sequence 5’ GAATTC 3’ generating 4 BP-long single stranded ends - known as sticky ends because they can rehybridize to each other or to any other piece of DNA cut with same enzyme.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How do DNA sequences create unique protein binding sites?

A

Sequence –> unique H-bonding sites in Major grooves for things like transcription factors & restriction enzymes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How is restriction enzyme digestion able to ID DNA being cut?

A

Digestion of a DNA sequence with a restriction enzyme gives a specific set of fragments. Gel electrophoresis can then be used to separate segments by size. Since DNA has a negative charge, when an electrical field is applied all fragments migrate, but the small fragments move faster and, thus, farther than the large. The segments can then be stained and visualized.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

True or false, gel electrophoresis is only used in DNA separation.

A

False, it’s also used for separating RNA & proteins by size. SDS can be used to first neutralize protein charge.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Southern Blotting

A
  • Used to ID a specific region of DNA.
  • Target DNA is ID’d based on restriction fragment SIZE plus hybridization to a PROBE.
  • A target DNA in a complex mixture, i.e. one gene in the entire genome, can be identified.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Southern Blotting steps:

A
  1. Genomic DNA is digested with a restriction enzyme.
  2. Fragments are separated by size on an agarose gel.
  3. DNA is denatured and transferred to a membrane.
  4. Membrane is incubated with a probe.
    * Probe: Defined piece of DNA homologous to target that is labelled with radioactivity or fluorescence for detection.
  5. Probe DNA is denatured and added to membrane.
  6. If DNA sequence encoded in the probe is present in the DNA mixture, then complementary strands of probe and target DNA will bind to each other.
  7. Sites of probe binding are visualized by radioactive or fluorescent tag on probe binding, which identifies sites where target DNA is present.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Sanger or conventional DNA Sequencing

A
  1. The DNA to be sequenced is denatured to provide a template for synthesis of a new strand. 2. Purified dNTPs are provided.
  2. The pool of normal dNTPs is spiked with a very low concentration of fluorescently-labeled ddNTP (such as ddTTP). Every where that an A is (for T ddTTP to bind) lights up.
    This occurs because ddTTP lacks a 3’ OH necessary for incoming dNTP’s to bind causing termination.
  3. Four sequencing reactions are required - one for each nt.
  4. All the fragments are separated by gel electro.
  5. Size of fragments corresponds to position of ddNTP in the sequence
  6. Position of fragments in gel corresponds to position of ddNTP in DNA sequence
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Polymerase Chain Reaction (PCR)

A
  • PCR AMPLIFIES a defined region of DNA *Extremely powerful b/c combines specificity AND amplification
  • Amplification by repeated cycles of in vitro DNA replication
  • Specificity because region to be amplified is determined by hybridization of short primers
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Steps in each PCR cycle:

A
  1. DNA is denatured, two strands separated
  2. Primers anneal flanking target region by complementary base pairing.
  3. Primers prime synthesis of complementary strands of target DNA in 5’ to 3’ direction.
  4. In the next round each of the new double stranded DNAs serve as templates for further amplification.
  5. End result is exponential amplification of starting DNA
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

PCR is an example of in vitro _____.

A

DNA synthesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

In PCR, _____determine the specific region of DNA that will be amplified.

A

Primers. Two are used so that both strands are replicated.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Clinical applications of DNA techniques

A

*Diagnosis of infectious diseases-
HPV, human papillomavirus:
–Some strains are causative agents for cervical cancer.
–Kit based on hybridization of RNA probes to viral DNA
–Probes are designed to be strain specific when used as screening tool

*Identification of mutations that cause hereditary diseases and risk factors-
BRCA1 and BRCA2:
–BRCA1 and BRCA2 mutations are by far the most prevalent breast cancer genetic risk factors
–Commercially available test by DNA sequencing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

EMERGING clinical application of DNA techniques: molecular prenatal diagnosis

A

Prenatal testing is routinely offered for trisomy 21, but it’s fairly invasive. Alternate approach: analyze fetal DNA in maternal blood to determine if levels of chromosome 21 are elevated. Maternal serum has both fetal and maternal cell free DNA. *If fetus has trisomy 21, maternal serum will have higher ratio of chromosome 21:chromosome 12.

  • Problem- concentration of fetal DNA is very low
  • **Solution - Digital PCR, extremely sensitive, is being developed to measure small excess DNA
18
Q

_______ is based on DNA-RNA binding, or hybridization, through complementary base pairing.

It is used to identify one target mRNA in a complex mixture, ie all RNAs expressed in a cell.

A

Northern blotting

19
Q

________ adapts PCR to quantitatively measure mRNA levels. What are the steps in this process?

A

RT-PCR (reverse transcriptase-PCR)
1. mRNA is converted to cDNA by reverse transcriptase.
2. Specific primers are used with PCR.
3. Fluorescent dye is incorporated as new
DNA is synthesized & amplified.
**The result is that the intensity of the fluorescence is proportional to the amount of mRNA initially present.

20
Q

Why is mRNA converted to cDNA in RT-PCR?

A

RNA not a template for most DNA polymerases

21
Q

Microarray analysis

A

Microarray analysis is used to determine global patterns of mRNA expression. The levels of 1000s of individual mRNAs are measured simultaneously. This is an extremely powerful technique which can identify individual genes whose expression changes in disease states. And possibly even more important it can identify patterns of mRNAs expressed in different diseases.

22
Q

Microarray technique summary:

A

Based on hybridization of a cDNA population derived from sample mRNAs to a grid containing known DNAs at specific locations.

23
Q

Microarray process:

A

Make array on chip:
1000s of short DNAs (oligos), 25 bases long.
Derived from genes to be analyzed
Arranged in grid- sequence, corresponding
gene and location for each oligo is known.
Up to 40,000 genes per chip!!!

24
Q

Microarray methodology:

A
  • mRNA population in patient’s cells are compared to mRNAs in reference sample
  • cDNAs derived from patient and reference mRNA populations are labelled with different fluorescent tags
  • Tagged cDNAs derived from original mRNAs are hybridized to an array of oligos representing mRNAs to be interrogated
  • Pattern of fluorescence on chip tells which mRNAs are present in each population and relative levels
25
Q

Microarray data analysis

A
  • Tells which mRNAs are present in each original sample
  • Tells relative levels of each mRNA in original samples- patient vs. reference
  • Defines signature for each patient sample
  • Does NOT tell which mRNA changes “cause” the disease
26
Q

Clinical applications of RNA techniques

A

RT-PCR or RT-PCR+sequencing-

  • -Identification of genetic alterations that affect protein coding regions
  • OTC used to ID fusion genes in leukemias and lymphomas
  • -ID of infectious agents
  • Screening blood pool or HIV

Microarray analysis-
*Oncotype DX- widely used test to determine risk of recurrence in breast cancer. Some results show tumors that would recur.

27
Q

Emerging RNA clinical application of RNA techniques: cancer classification

A

Identifying different sub-groups among cancer patients and tailoring therapies accordingly.

28
Q

The foundation of most protein characterization techniques is the specific interaction
between an _____ and a protein.

A

antibody

29
Q

Natural function of antibodies:

A

*Antibodies are proteins made by B cells as part of the immune response.
*Antibodies bind foreign proteins and tag them for processing by the immune system.
*An individual has the potential to make an almost infinite number of different antibodies
with different binding sites.

30
Q

Antibody structure

A

Variable regions- differ among antibodies,
bind specific proteins (ends of “Y”)
Constant regions- constant among same
class of antibodies (The stem of the “Y”)

31
Q

_______ recognizes specific target protein in protein testing.

A

Primary antibody

32
Q

______ has tag that emits signal when activated and recognizes constant region of primary antibody. True/false, these can be used for all primary antibodies with same constant region.

A

Secondary antibody

33
Q

ELISA- enzyme linked immunosorbent assay

A

Used to detect specific protein in complex mixture
High throughput and quantitative
Used extensively clinically

Also based on specific interaction of protein with antibody, but NO separation by size (so not as specific as W Blot)

34
Q

How does ELISA work? Use HIV as an example.

A

Recombinant HIV proteins are immobilized on agarose beads or on the wells of a 96 well plate. These proteins serve as bait for HIV antibodies in the patient’s serum. If the patient’s serum contains HIV antibodies, they will bind to the immobilized HIV protein antigen and also become immobilized. Unbound antibodies will be washed away. Bound antibodies are detected using a secondary antibody conjugated to an enzyme which causes a substrate to change color. The color change is detected and quantitated by an automatic plate reader. Darker color means higher [antibody].

35
Q

Western blotting

A
  • Identifies a specific protein in a complex mix, ie total cell lysate
  • Target protein is identified by size AND specific interaction between antibody and protein…similar to Southern and Northern Blotting, but looking at proteins
  • -Size fractionation of protein mixture
  • -Specific binding of antibody to target protein
  • -Detection using secondary antibody

Comparable to Southern and Northern blotting

36
Q

How western blotting works

A
  1. Preparation of protein - protein is denatured and incubated with SDS to give a uniform mass to charge ratio so that migration depends on mass not native charge or shape.
  2. Proteins are size fractionated on a polyacrylamide gel (SDS-PAGE).
  3. Proteins are transferred to a membrane.
  4. Membrane is incubated with primary antibody specific for target protein.
  5. The position of he primary antibody and target protein are visualized using a secondary antibody. The secondary antibody binds to the conserved constant region so that the same secondary can be used for many primaries. The secondary antibody is conjugated to an enzyme that cleaves a substrate to release light. Signal is detected only at the site of the target protein.
37
Q

Significance of Western Blotting:

A

Western blotting is essential for research to identify changes in protein expression and modification during pathogenesis but it is labor intensive and difficult to quantitate so is not commonly used as a first round test.

38
Q

Emerging application: therapeutic antibodies

A

Because of specificity antibodies have great potential as therapeutic anti-cancer agents. By blocking cell surface receptor, antibodies could evoke desirable immune responses, deliver toxin or radioactive material to kill cancer cells, for example.

39
Q

Herceptin and Her2

A

HER2 is a member of the epidermal growth factor receptor family. Overexpression of HER2 –> 25% of breast cancers. Herceptin blocks HER2 growth factor receptor

40
Q

Next Generation Sequencing, aka massively parallel, deep sequencing:

A

massively parallel- make millions of short fragments and sequenced in one run
quantitative- digital readout gives number of fragments with a given sequence
IOW - it’s waaaaay faster and gives more information than conventional/Sanger sequencing.

41
Q

Next Generation Sequencing Goals & Limitations:

A
  • Identify mutations or genetic variants that cause inherited diseases or susceptibility to diseases
  • Identify somatic mutations in cancers
  • cost still high
  • interpretation- which sequence differences are important
  • **Most limiting - effective treatments are often not available ***
42
Q

RNA interference, RNAi

A

Small non-coding RNAs regulate gene expression in the cell by targeting specific mRNAs.E.g. microRNA (miRNA) & Short interfering RNA (siRNA)

Clinical potential is to specifically deplete
mRNAs involved in disease by synthesizing miRNA and getting it to target tissues.